Silo Pharma Files S-1/A Amendment

Ticker: SILO · Form: S-1/A · Filed: May 9, 2025 · CIK: 1514183

Silo Pharma, Inc. S-1/A Filing Summary
FieldDetail
CompanySilo Pharma, Inc. (SILO)
Form TypeS-1/A
Filed DateMay 9, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, s-1/a, pharmaceutical

TL;DR

Silo Pharma (formerly Uppercut Brands) filed an S-1/A. Looks like they're still trying to raise capital.

AI Summary

Silo Pharma, Inc. filed an S-1/A amendment on May 9, 2025, for its registration statement (No. 333-286777). The company, formerly known as Uppercut Brands, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at 677 N. Washington Blvd, Sarasota, Florida.

Why It Matters

This filing indicates Silo Pharma is actively pursuing a securities offering or other regulatory actions, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — S-1/A filings often relate to capital raises or significant corporate changes, which inherently carry risks for investors.

Key Numbers

  • 333-286777 — SEC File Number (Identifies this specific registration filing)
  • 20250509 — Filing Date (Indicates when the amendment was submitted to the SEC)

Key Players & Entities

  • Silo Pharma, Inc. (company) — Registrant
  • 0001514183 (company) — Central Index Key
  • 2834 (company) — Standard Industrial Classification Code
  • 462137136 (company) — EIN
  • NV (company) — State of Incorporation
  • 1231 (company) — Fiscal Year End
  • 333-286777 (company) — SEC File Number
  • 677 N. Washington Blvd, Sarasota, Florida 34236 (company) — Business Address
  • (718) 400-9031 (company) — Business Phone
  • Uppercut Brands, Inc. (company) — Former Company Name

FAQ

What is the purpose of this S-1/A filing?

This is an amendment to Silo Pharma, Inc.'s S-1 registration statement, indicating ongoing efforts related to securities registration.

When was Silo Pharma, Inc. previously known by another name?

Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., with a name change effective August 8, 2019.

Where is Silo Pharma, Inc. headquartered?

Silo Pharma, Inc.'s principal executive offices are located at 677 N. Washington Boulevard, Sarasota, Florida 34236.

What industry does Silo Pharma, Inc. operate in?

Silo Pharma, Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification Code of 2834.

Who is the Chief Executive Officer of Silo Pharma, Inc.?

Eric Weisblum is the Chief Executive Officer of Silo Pharma, Inc.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on May 9, 2025 regarding Silo Pharma, Inc. (SILO).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.